Beyond the Pitch
Nationwide Children’s Hospital Dedicated to Life-saving Gene Therapies
It is excellent to see a local leader featured in this inspiring Xconomy story about Nationwide Children’s Hospital’s brave commitment to saving children’s lives by researching, testing, and spinning out promising gene therapies.
This quote from Xconomy says it all:
“Thanks to ambitious officials, a risk-taking administration, and a tight connection between its labs and its hospital practice, Nationwide has become a gene therapy leader.” — Ben Fidler, Xconomy
At Rev1, we see first-hand the incredible dedication of the scientists and entrepreneurs from the Columbus region who are mentioned in the article.
Rev1 manages the NCH Fund I, which focuses on Nationwide Children’s Hospital spinouts as well as the Catalyst Fund, which includes investments from The Ohio State University, Nationwide Children’s Hospital, Ohio Third Frontier, and Rev1 Ventures. Two of the companies mentioned in this article, Celenex (Acquired by Amicus Therapeutics) and Myonexus Therapeutics (acquired by Sarepta).
We celebrate their persistence and groundbreaking discoveries.
Read the entire Xconomy article.
Search Our Blog
Get startup tips and resources delivered directly to your inbox.
Tips for turning a concept into a company
From honing your pitch to getting your first customer
How and where to get the cash you need to grow
The Hard Stuff
How to navigate hiring, taxes, legal and more
The Network Effect
Making the right connections at the right time
The news and trends that matter to you
Rev1 News & Events
The latest buzz and networking opportunities